Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nitroglycerin added to first-line chemotherapy for advanced non-small cell lung cancer
NL-OMON38964Phase 3Active, not recruiting
- Sponsor
- NVALT
- Start
- Oct 2013
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of nitroglycerin in non-small cell lung cancer (NSCLC), sponsored by NVALT. Primary endpoint: Progression-free survival. Started Oct 2013; status: active, not recruiting.
02
Drugs
nitroglycerin
03
Conditions
non-small cell lung cancer (NSCLC)
Beyond the preview
Go deeper on NL-OMON38964.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON38964.